Background-A study was undertaken to investigate the accuracy of typing of a series of bronchial carcinomas by experienced pathologists with an interest in lung cancer from the examination of bronchoscopic biopsy specimens. Methods-Eighty bronchial biopsy specimens showing positive results for bronchial carcinoma were circulated to five pathologists, who recorded diagnostic criteria and diagnosis for each. Diagnoses were then compared with the diagnosis agreed from the resection specimen corresponding to each biopsy specimen. A "non-small cell carcinoma, not further specified" classification group was introduced for small biopsy specimens. Results-A diagnostic accuracy of 75% was achieved for squamous cell carcinomas, 66% for small cell carcinomas, and 50% for adenocarcinomas. There was diagnostic confusion between small cell and non-small cell carcinoma in less than 10% of cases. The introduction of a non-specific non-small cell classification improved diagnostic accuracy by 10-15% for each non-small cell tumour group. Conclusions-There are appreciable inaccuracies in applying the World Health Organisation's 1981 classification of lung cancer to the diagnosis of bronchial carcinoma from small biopsy specimens and these inaccuracies have been measured. They can be diminished by introducing a less specific "non-small cell" category for use with this sort of biopsy material. Care should be taken not to overinterpret small biopsy specimens in lung cancer. (Thorax 1993; 48:1 135-1139) Different histological subtypes of lung cancer (appendix 1) undoubtedly respond to different therapeutic regimens,1"5 but patients are often given specific treatments from the results of typing performed on small bronchoscopic biopsy specimens, which may not be representative of the whole tumour.
As the proportion of unrepresentative or misclassified small biopsy specimens is not known, the problem was explored by a group of experienced histopathologists with a special interest in lung cancer. Noting that there was no scope within the 1981 classification of the World Health Organisation to make a non-specific diagnosis which could be refined later if further tissue became available,6 we addressed the question: what percentage of the different cell types are correctly diagnosed compared with those that are either not specifically diagnosed or incorrectly diagnosed?
The results of a parallel analysis of the accuracy of tumour diagnosis and classification using cytological material was also carried out and will be published elsewhere.
Methods
The histological subtypes set out in appendix 2 and based on the 1981 WHO classification were first agreed. This modified the WHO classification in that category 4 allows the grouping together of unusual tumours such as adenosquamous carcinoma and carcinoid tumours, and category 5 allows for a diagnosis of "non-small cell carcinoma, not otherwise specified." The diagnostic criteria for each subtype were agreed after lengthy discussions by the whole group (appendix 3). The numbering of these criteria is used in the same way throughout this paper. The criteria are grouped together because of assumed associations with particular tumour types: criteria 1-4 with squamous carcinoma, 5-13 with small cell carcinoma, and 14-18 with adenocarcinoma. Definitions of the diagnostic criteria and diagnostic categories are listed in appendix 4. Eighty biopsy specimens of lung cancer were retrieved from the departmental files of the participating pathologists; contemporaneous cytological specimens and resection specimens were also available. All biopsy specimens were of the type obtained during fibreoptic bronchoscopy. Sections stained by haematoxylin and eosin and alcian blue/periodic acid-Schiff-diastase (AB/PAS-D) were available for examination. This selection inevitably resulted in the underrepresentation of small cell carcinomas because they are less often removed surgically (see table 1 ).
The 80 small biopsy specimens (single slides + AB/PAS-D) were sent in turn to five participating pathologists, who returned their findings for each of the diagnostic criteria and their diagnoses to the central coordinator (RJS) for collation and analysis. To examine the criteria used for diagnosis of the subtypes the pathologists were instructed to examine each criterion in turn, recording a positive or negative as appropriate before recording their diagnoses. The resected tumours (multiple slides) corresponding to the small biopsy specimens were circulated to three pathologists, who agreed the diagnoses and the diagnostic criteria.
Results
The small biopsy material provided a total of 400 possible diagnoses (80 cases or slides x five participating pathologists).
ACCURACY OF BIOPSY DIAGNOSES
The number of cases of each type as judged by the resected specimens is shown in relation to the typing of small biopsy specimens by the five pathologists in table 1.
The vertical total column gives the distribution of the observations of the five pathologists in relation to the small biopsy specimens; the horizontal row gives the distribution of the observations of the five pathologists in relation to the resected specimens. Note that undifferentiated large cell carcinomas were not expected to-be recognised in the small biopsy specimens.
Within the matrix "correct" attributionsthat is, the biopsy typing coincided with the resection typing-are in bold, "wrong" attributions-that is, the biopsy typing did not coincide with the resection typing-are in italic type, and "not incorrect" attributionsthat is, the biopsy typing was correct as far as it went, such as a biopsy typing of non-small cell carcinoma relating to a resection typing of adenocarcinoma-are in plain type. Table 2 shows that the small biopsy specimens from the squamous carcinomas were wrongly typed by the five pathologists in 9% (20/210) of readings, small cell carcinomas in 7% (2/30), and adenocarcinomas in 22% (22/100); they were correctly typed as squa- tNumber is category given in appendices 2 and 4. Table 5 shows the change in distribution of diagnoses in the resection specimens compared with their corresponding biopsy specimens. The principal difference was a substantially reduced number of non-specific (principally category 5) diagnoses in the resection cases. This is to be expected given the greater amount of material available for examination.
Discussion POOR TYPING ACCURACY
The diagnosis of lung cancer itself is reliable in small biopsy specimens but the diagnosis of subtypes on which treatment is decided is unreliable. The shortcomings stem both from inappropriate application of the existing classification and also from inadequacies of the classifications themselves.7-9 In particular, the existing classifications fail to allow for the small biopsy specimens to be representative enough for specific categorisation of a tumour. The introduction of the two categories, non-small cell carcinoma of specified type and non-small carcinoma, not otherwise specified (categories 4 and 5 in appendix 2) in our provisional classification has allowed us to explore the scale of this problem and provide answers to most of our original questions.
We appreciate that this study does not entirely reflect what happens clinically, where additional cytological material might be available. It is accepted that the accuracy of tumour typing can be improved by coexamination of cytological material, but we decided at the outset of the study to run a parallel cytological study rather than a combined cytological-histological study, which might have confused our results.
SQUAMOUS V ADENOCARCINOMA
Our results show that the accuracy of diagnosis from small biopsy specimens is strongly affected by tumour type-75% of squamous carcinomas versus less than 50% of adenocarcinomas, for which there is also poor unanimity of diagnosis. This may be because pathologists have difficulty in deciding, for example, how many acinar structures or how much mucin is required to diagnose adenocarcinoma. This is examined further in the discussion of criteria.
The review of the resected specimens was carried out on the basis of the WHO classification6 rather than the modified form that we used for the biopsy specimens, which contains a number of catch all categories to enable the pathologist to subclassify a tumour while leaving scope for further refinement if more tissue is obtained by resection or at necropsy. It seemed preferable to make a diagnosis that was not incorrect-for example, non-small cell tumour, not otherwise specified (category 5)-which could be revised later, than to make one that was wrong because of inadequate sampling. It is, therefore, not surprising that the resection specimen diagnoses are more specific ( We have shown the shortcomings of the 1981 WHO classification with small biopsy specimens. Table 5 shows a substantial drop in the number of non-specific, non-small cell diagnoses made on resection specimens compared with their corresponding biopsy specimens. This fall is parallelled by a rise in specific diagnoses. The major shortcoming of the WHO (1981) classification is the lack of a diagnostic group that allows the tumour to be classified as non-small cell carcinoma with the view that this diagnosis may be refined further should more diagnostic material become available. The other principal area of difference in our provisional classification is the amalgamation of unusual specified tumours-for example, adenosquamous carcinoma and carcinoid tumours-into one group from which more detailed information may be abstracted subsequently. This gives a less cumbersome classification that is easier to manage and interpret.
Several problems could not be resolved by this study. For 
